Exercise training-enhanced reactive oxygen species as protective mechanisms in the coronary microcirculation
运动训练增强活性氧作为冠状动脉微循环的保护机制
基本信息
- 批准号:9914125
- 负责人:
- 金额:$ 60.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAngiographyAreaAutomobile DrivingBiochemicalBiologyBlood VesselsBlood flowCalciumCardiacCardiovascular systemCause of DeathCellsChronicCoronaryCoronary ArteriosclerosisCoronary CirculationCoronary OcclusionsCyclic AMP-Dependent Protein KinasesDataDevelopmentDimerizationDiseaseDobutamineElectron MicroscopyElectron Spin Resonance SpectroscopyEndothelial CellsEndotheliumEvaluationExerciseFamily suidaeFluorescence Resonance Energy TransferGoalsHealthHealthcareHeartHeart DiseasesHumanHydrogen PeroxideImmunofluorescence ImmunologicIn VitroKnowledgeLabelLeftMeasuresMediatingMicrocirculationMicrospheresMitochondriaModelingMolecularMyocardialMyocardial IschemiaMyocardial perfusionMyocardiumMyosin Light ChainsNADPH OxidasePathway interactionsPatientsPerfusionPharmacologyPhysical activityPhysiologicalPlayPotassium ChannelPreventionProductionProductivityProtein DephosphorylationProtein IsoformsProtein SubunitsProteinsQuality of lifeQuantitative Reverse Transcriptase PCRReactive Oxygen SpeciesRegional PerfusionReportingRestRiskRoleSecondary PreventionSignal PathwaySignal TransductionSmall Interfering RNASourceStressSuperoxidesTherapeuticTransfectionVascular SystemVasodilationVentricularWomanWorkloadarteriolebasecardioprotectioncofactorcoronary artery occlusioncostcost effectiveeffective interventionexercise trainingexperimental studyheart functionimprovedin vivoinsightmenmultidisciplinarynew therapeutic targetnovelnovel therapeutic interventionpatch clampresponserestorationsedentaryvascular contributionsvoltage
项目摘要
Project Summary
Regular exercise is a proven, powerful and cost-effective intervention for the treatment and secondary
prevention of coronary artery disease. However, a detailed understanding of the fundamental cellular and
molecular mechanisms that underlie exercise-induced cardioprotection are lacking, limiting the development of
effective new therapeutic strategies for diseased patients. Despite recent advances in the appreciation of
reactive oxygen species (ROS) as critical regulators of cell signaling, the details of the specific contributions of
these molecules to physiologic signaling and functional adaptions in the vascular system remain to be
elucidated. This is particularly true in the coronary microcirculation where studies determining the contributions
of ROS in the control of blood flow are sparse. The proposed studies will utilize a combination of in vitro and in
vivo approaches to determine how exercise-induced adaptations in ROS signaling affect vascular reactivity
and coronary blood flow into both control and ischemic myocardium, an area that has been largely unexplored
in the coronary circulation. The overarching hypothesis is that ROS play a critical and protective role in the
exercise training-induced restoration of vasodilation responses in the coronary microcirculation and thereby
enhances perfusion and contractile function of the at-risk myocardium. Aim 1 will determine exercise training-
induced adaptations in ROS production in hearts subjected to chronic coronary artery occlusion. Aim 2 will
determine the effects of exercise training on the expression and subcellular localization of candidate sources of
ROS production and associated regulatory subunit proteins in microvascular endothelium of hearts subjected
to chronic coronary artery occlusion. Aim 3 will identify the adaptations by which exercise training promotes
downstream signaling pathway(s) for ROS-mediated dilation in arterioles isolated from hearts subjected to
chronic coronary artery occlusion. Aim 4 will identify the signaling mechanisms by which exercise training
enhances regional perfusion and myocardial contractile function at rest and during dobutamine-induced
myocardial stress in hearts subjected to chronic coronary occlusion. These studies are of high impact since the
knowledge gained will provide novel insight into the protective role of ROS in the cardiovascular system. The
proposed studies will provide important new information with significant mechanistic insight into human
ischemic heart disease and identify the role of ROS signaling in the control of coronary blood flow in health,
disease, and exercise adaptation.
项目摘要
定期锻炼是一种被证实的、有效的、成本效益高的治疗和继发性心脏病的干预措施
预防冠心病。然而,详细了解基本的细胞和
缺乏运动诱导的心脏保护的分子机制,限制了
为疾病患者制定有效的新治疗策略。尽管最近在升值方面取得了进展
活性氧物种(ROS)作为细胞信号转导的关键调节物质,其具体贡献的细节
这些分子对血管系统中的生理信号和功能适应仍有待研究
已澄清。在冠脉微循环中尤其如此,在那里研究确定贡献
ROS在控制血流方面的作用是稀少的。拟议的研究将利用体外和体内研究的组合。
确定运动诱导的ROS信号适应如何影响血管反应性的活体方法
冠状动脉血流同时流入对照和缺血心肌,这是一个在很大程度上尚未被探索的区域
在冠脉循环中。最重要的假设是,ROS在
运动训练诱导冠脉微循环血管扩张反应的恢复
增强高危心肌的灌流和收缩功能。目标1将决定运动训练-
慢性冠状动脉闭塞心脏ROS产生的诱导适应。目标2将
确定运动训练对候选信号源的表达和亚细胞定位的影响
大鼠心脏微血管内皮细胞ROS产生及相关调节亚基蛋白
到慢性冠状动脉闭塞。目标3将确定运动训练促进的适应
ROS介导的心脏微动脉扩张的下游信号通路(S)
慢性冠状动脉闭塞。目标4将确定运动训练的信号机制
增强静息和多巴酚丁胺诱导的心肌局部血流灌注和心肌收缩功能
慢性冠脉闭塞心脏的心肌应激反应。这些研究具有很高的影响,因为
所获得的知识将为ROS在心血管系统中的保护作用提供新的见解。这个
拟议的研究将提供重要的新信息,对人类有重大的机械性洞察
并确定ROS信号在控制健康人冠状动脉血流量中的作用,
疾病和运动适应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRISTINE L HEAPS其他文献
CRISTINE L HEAPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRISTINE L HEAPS', 18)}}的其他基金
Adenosine-activation of voltage-dependent K+ currents
电压依赖性 K 电流的腺苷激活
- 批准号:
6584215 - 财政年份:2003
- 资助金额:
$ 60.33万 - 项目类别:
Adenosine-activation of voltage-dependent K+ currents
电压依赖性 K 电流的腺苷激活
- 批准号:
6693853 - 财政年份:2002
- 资助金额:
$ 60.33万 - 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
- 批准号:
7267078 - 财政年份:2000
- 资助金额:
$ 60.33万 - 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
- 批准号:
7880939 - 财政年份:2000
- 资助金额:
$ 60.33万 - 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
- 批准号:
7099840 - 财政年份:2000
- 资助金额:
$ 60.33万 - 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
- 批准号:
7468466 - 财政年份:2000
- 资助金额:
$ 60.33万 - 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
- 批准号:
7651232 - 财政年份:2000
- 资助金额:
$ 60.33万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 60.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 60.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 60.33万 - 项目类别:














{{item.name}}会员




